Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
LMRI
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. (LMRI) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B+); its weakest is Growth (C-).
Quantitative Factor Evaluation • Updated
Overall Rating
2.7
/ 5.0
C+
Value
C+
Factor Score
2.7
/ 5.0
Growth
C-
Factor Score
2.1
/ 5.0
Profitability
C+
Factor Score
2.7
/ 5.0
Momentum
B+
Factor Score
3.5
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
16.1
EV / EBITDA
30.9
Rev Growth YoY
5.0%
Gross Margin
15.4%
Price Return 3M
24.3%
Price Return 12M
-19.3%
Catalyst Signal
0.00
Market Cap
$1.4B
TTM Revenue
$1.1B
Price / Sales
1.4
ROE
-4.3%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-13 | C+ (2.7) | C- (2.1) | C+ (2.7) | B+ (3.5) | C+ (2.6) | C+ (2.7) |
| 2026-11-06 | C+ (2.7) | C (2.2) | D+ (1.5) | B- (3.0) | C+ (2.7) | C (2.4) |
| 2026-10-30 | B- (2.9) | C- (2.1) | D+ (1.5) | B- (2.9) | C+ (2.7) | C (2.4) |
| 2026-10-23 | B- (2.9) | C- (2.1) | D+ (1.5) | C+ (2.6) | C+ (2.6) | C (2.4) |
| 2026-10-16 | B- (2.9) | C- (2.1) | D+ (1.5) | B- (2.9) | C+ (2.6) | C (2.4) |
Page
1
of
4